Skip to main content
SpringerLink
Log in

Neurogenic Bladder Sphincter Dysfunction

  • Chapter
  • First Online:
An Illustrated Guide to Pediatric Urology

  • 2185 Accesses

Abstract

Neurogenic bladder sphincter dysfunction (NBSD) can develop as a result of a lesion at any level in the nervous system, including:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  1. Amark P, Bussman G, Eksborg S. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children. Eur Urol. 1998;34:148–53.

    Article  CAS  PubMed  Google Scholar 

  2. Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol. 2009;55(1):100–19.

    Google Scholar 

  3. Baskin LS, Kogan BA, Benard F. Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol. 1990;66:532–4.

    Article  CAS  PubMed  Google Scholar 

  4. Buyse G, Verpoorten C, Vereecken R, Casaer P. Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self) catheterisation and optimized intravesical oxybutynin hydrochloride therapy. Eur J Pediatr Surg. 1995;5:31–4.

    Article  PubMed  Google Scholar 

  5. Buyse G, Waldeck K, Verpoorten C, Björk H, Casaer P, Andersson KE. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol. 1998;160:892–6.

    Article  CAS  PubMed  Google Scholar 

  6. De Wachter S, Wyndaele JJ. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol. 2003;169:1892–5.

    Article  CAS  PubMed  Google Scholar 

  7. Edelstein RA, Bauer SB, Kelly MD, Darbey MM, Peters CA, Atala A, Mandell J, Colodny AH, Retik AB. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol. 1995;154:1500–4.

    Article  CAS  PubMed  Google Scholar 

  8. Fernandes E, Reinberg Y, Vernier R, Gonzales R. Neurogenic bladder dysfunction in children: review of pathophysiology and current management. J Pediatr. 1994;124:1–7.

    Article  CAS  PubMed  Google Scholar 

  9. Frenkl TL, Rackley RR. Injectable neuromodulatory agents: botulinum toxin therapy. Urol Clin N Am. 2005;32(1):89–99.

    Article  Google Scholar 

  10. Goessl C, Sauter T, Michael T, Bergé B, Staehler M, Miller K. Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia. Urology. 2000;55:414–8.

    Article  CAS  PubMed  Google Scholar 

  11. Jeruto A, Poenaru D, Bransford R. Clean intermittent catheterisation: overview of results in 194 patients with spina bifida. Afr J Pediatr Surg. 2004;1:20–3.

    Google Scholar 

  12. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol. 1999;162:1068–71.

    Article  CAS  PubMed  Google Scholar 

  13. Kasabian NG, Bauer SB, Dyro FM, Colodny AH, Mandell J, Retik AB. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child. 1992;146:840–3.

    CAS  PubMed  Google Scholar 

  14. Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H. Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele. Neurourol Urodyn. 2006;25:758–62.

    Article  PubMed  Google Scholar 

  15. Kurzrock EA, Polse S. Renal deterioration in myelodysplastic children: urodynamic evaluation and clinical correlates. J Urol. 1998;159:1657–61.

    Article  CAS  PubMed  Google Scholar 

  16. Madersbacher H. Neurogenic bladder dysfunction in patients with myelomeningocele. Curr Opin Urol. 2002;12:469–72.

    Article  PubMed  Google Scholar 

  17. McKibben MJ, Seed P, Ross SS, Borawski KM. Urinary tract infection and neurogenic bladder. Urol Clin N Am. 2015;42(4):527–36.

    Article  Google Scholar 

  18. Snodgrass WT, Adams R. Initial urologic management of myelomeningocele. Urol Clin N Am. 2004;31:427–34.

    Article  Google Scholar 

  19. Sutherland RS, Kogan BA, Baskin LS, Mevorach RA. Clean intermittent catheterization in boys using the LOFric catheter. J Urol. 1996;156:2041–3.

    Article  CAS  PubMed  Google Scholar 

  20. van Gool JD, Dik P, de Jong TP. Bladder sphincter dysfunction in myelomeningocele. Eur J Pediatr. 2001;160:414–20.

    Article  PubMed  Google Scholar 

  21. Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol. 2006;175(3 Pt 2):S5–10.

    Article  PubMed  Google Scholar 

  22. Zegers B, Uiterwaal C, Kimpen J, et al. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization. J Urol. 2011;186(6):2365–71.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Surgery, AlSadik Hospital, Qatif, Saudi Arabia

    Ahmed H. Al-Salem

Authors
  1. Ahmed H. Al-Salem
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Al-Salem, A.H. (2017). Neurogenic Bladder Sphincter Dysfunction. In: An Illustrated Guide to Pediatric Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-44182-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44182-5_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44181-8

  • Online ISBN: 978-3-319-44182-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation